Mucosal delivery of vaccine antigens and its advantages in pediatrics

被引:96
作者
De Magistnis, MT [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
关键词
vaccines; mucosal immune system; adjuvants; delivery systems; mucosal vaccines; pediatric vaccines; mechanism of action of adjuvants;
D O I
10.1016/j.addr.2006.01.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery of vaccines through the mucosal route is very practical, non-invasive and efficacious for the induction of mucosal and systemic immune responses. Appropriately formulated mucosal vaccines can stimulate all arms of the immune system and could be exploited for protection against pathogens that infect the host through the mucosal surfaces as well as those acquired through other routes. There are few available mucosal vaccines so far and these are mainly based on whole microorganisms. The development of new generation mucosal vaccines based on purified protective antigens has been hampered for a long time by the low immunogenicity of soluble antigens and by the lack of safe and efficacious mucosal adjuvants. However, we have now several promising candidate adjuvants and delivery systems for mucosal immunization. In this review I will illustrate the advantages of mucosal vaccination and I will discuss what we still need to develop safe and efficacious mucosal vaccines that would be beneficial especially for young children. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 67
页数:16
相关论文
共 149 条
[71]   RANTES potentiates antigen-specific mucosal immune responses [J].
Lillard, JW ;
Boyaka, PN ;
Taub, DD ;
McGhee, JR .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :162-169
[72]   Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro [J].
Lutsiak, MEC ;
Robinson, DR ;
Coester, C ;
Kwon, GS ;
Samuel, J .
PHARMACEUTICAL RESEARCH, 2002, 19 (10) :1480-1487
[73]   Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA [J].
Marinaro, M ;
Riccomi, A ;
Rappuoli, R ;
Pizza, M ;
Fiorelli, V ;
Tripiciano, A ;
Cafaro, A ;
Ensoli, B ;
De Magistris, MT .
VACCINE, 2003, 21 (25-26) :3972-3981
[74]   Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens [J].
Marinaro, M ;
Di Tommaso, A ;
Uzzau, S ;
Fasano, A ;
De Magistris, MT .
INFECTION AND IMMUNITY, 1999, 67 (03) :1287-1291
[75]   Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses [J].
Marinaro, M ;
Fasano, A ;
De Magistris, MT .
INFECTION AND IMMUNITY, 2003, 71 (04) :1897-1902
[76]   Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material197 vaccine [J].
Mawas, F ;
Peyre, M ;
Beignon, AS ;
Frost, L ;
Del Giudice, G ;
Rappuoli, R ;
Muller, S ;
Sesardic, D ;
Partidos, CD .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (06) :1177-1182
[77]  
McCluskie MJ, 2001, CRIT REV IMMUNOL, V21, P103
[78]   Poxvirus tropism [J].
McFadden, G .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :201-213
[79]   THE MUCOSAL IMMUNE-SYSTEM - FROM FUNDAMENTAL-CONCEPTS TO VACCINE DEVELOPMENT [J].
MCGHEE, JR ;
MESTECKY, J ;
DERTZBAUGH, MT ;
ELDRIDGE, JH ;
HIRASAWA, M ;
KIYONO, H .
VACCINE, 1992, 10 (02) :75-88
[80]   A mucosal vaccine against diphtheria:: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery [J].
McNeela, EA ;
O'Connor, D ;
Jabbal-Gill, I ;
Illum, L ;
Davis, SS ;
Pizza, M ;
Peppoloni, S ;
Rappuoli, R ;
Mills, KHG .
VACCINE, 2000, 19 (9-10) :1188-1198